These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28456641)

  • 1. Low-density lipoprotein oxidation biomarkers in human health and disease and effects of bioactive compounds.
    Winklhofer-Roob BM; Faustmann G; Roob JM
    Free Radic Biol Med; 2017 Oct; 111():38-86. PubMed ID: 28456641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases.
    Aviram M
    Free Radic Res; 2000 Nov; 33 Suppl():S85-97. PubMed ID: 11191279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is oxidized low-density lipoprotein present in vivo?
    Ylä-Herttuala S
    Curr Opin Lipidol; 1998 Aug; 9(4):337-44. PubMed ID: 9739490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
    Verhoye E; Langlois MR;
    Clin Chem Lab Med; 2009; 47(2):128-37. PubMed ID: 19099526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction, oxidation of low-density lipoprotein, and cardiovascular disease.
    Holvoet P
    Ther Apher; 1999 Nov; 3(4):287-93. PubMed ID: 10608719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dietary factors on oxidation of low-density lipoprotein particles.
    Lapointe A; Couillard C; Lemieux S
    J Nutr Biochem; 2006 Oct; 17(10):645-58. PubMed ID: 16517144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxysterols and 4-hydroxy-2-nonenal contribute to atherosclerotic plaque destabilization.
    Gargiulo S; Testa G; Gamba P; Staurenghi E; Poli G; Leonarduzzi G
    Free Radic Biol Med; 2017 Oct; 111():140-150. PubMed ID: 28057601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease.
    Fraley AE; Tsimikas S
    Curr Opin Lipidol; 2006 Oct; 17(5):502-9. PubMed ID: 16960498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans.
    Aviram M; Dornfeld L; Kaplan M; Coleman R; Gaitini D; Nitecki S; Hofman A; Rosenblat M; Volkova N; Presser D; Attias J; Hayek T; Fuhrman B
    Drugs Exp Clin Res; 2002; 28(2-3):49-62. PubMed ID: 12224378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde adducts generated during lipid peroxidation modification of proteins.
    Uchida K
    Free Radic Res; 2015; 49(7):896-904. PubMed ID: 25968950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of oxidative damage and antioxidant protection: assessment of LDL oxidation.
    Salonen JT
    Free Radic Res; 2000 Nov; 33 Suppl():S41-6. PubMed ID: 11191274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of lipid peroxidation in human low density lipoprotein.
    Quehenberger O; Koller E; Jürgens G; Esterbauer H
    Free Radic Res Commun; 1987; 3(1-5):233-42. PubMed ID: 3508434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline diene conjugation in LDL lipids: an indicator of circulating oxidized LDL.
    Ahotupa M; Asankari TJ
    Free Radic Biol Med; 1999 Dec; 27(11-12):1141-50. PubMed ID: 10641705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Oxidation Products in the Pathogenesis of Inflammation-related Gut Diseases.
    Sottero B; Rossin D; Poli G; Biasi F
    Curr Med Chem; 2018; 25(11):1311-1326. PubMed ID: 28625152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia.
    van Tits LJ; Smilde TJ; van Wissen S; de Graaf J; Kastelein JJ; Stalenhoef AF
    J Investig Med; 2004 Apr; 52(3):177-84. PubMed ID: 15222407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis.
    Newcombe J; Li H; Cuzner ML
    Neuropathol Appl Neurobiol; 1994 Apr; 20(2):152-62. PubMed ID: 7521019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a dietary oxidized fat on cholesterol in plasma and lipoproteins and the susceptibility of low-density lipoproteins to lipid peroxidation in guinea pigs fed diets with different concentrations of vitamins E and C.
    Eder K; Keller U; Brandsch C
    Int J Vitam Nutr Res; 2004 Jan; 74(1):11-20. PubMed ID: 15060896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.